XML 31 R14.htm IDEA: XBRL DOCUMENT
v3.22.4

Shareholders' Equity | 12 Months Ended
--- | ---
Dec. 31, 2022
Stockholders' Equity Note [Abstract] |
SHAREHOLDERS' EQUITY | NOTE 6 - SHAREHOLDERS’ EQUITY
| a. | Share capital:
The Company’s ordinary shares are traded in the United States on the Nasdaq Global Market, under the symbol MNDO. Ordinary shares of the Company confer upon their holders the right to receive notice to participate and vote in general meetings of the Company and the right to receive dividends, if and when, declared.
| b. | Treasury shares:
During the period between September 2008 and December 2009, the Company has purchased an aggregate number of 3,165,092 ordinary shares for a total consideration of approximately $2.8 million. Currently, the Company does not have an active buyback plan. As of December 31, 2022, the remaining treasury shares are 1,535,684 which amounted to $1,058 thousand. The treasury shares are mainly utilized by the Company to settle exercise of options by employees.
| c. | Dividend:
Dividends paid per share in the years ended December 31, 2022, 2021 and 2020 were $0.26, $0.26 and $0.24, respectively. The Company paid dividends to its shareholders in the amounts of approximately $5.2 million, $5.2 million and $4.8 million during the years ended December 31, 2022, 2021 and 2020, respectively.
| d. | Stock option plan:
In 2011, the Board of Directors and the Company’s shareholders approved a share incentive plan (the “2011 Share Incentive Plan”). Under the 2011 Share Incentive Plan, options for up to 1,800,000 ordinary shares of NIS 0.01 par value can be granted to employees, directors, consultants or contractors of the Company and its subsidiaries. Each option can be exercised to purchase one ordinary share. Immediately upon issuance, the ordinary shares issuable upon the exercise of the options will confer on holders the same rights as the other ordinary shares. The Board of Directors determines the exercise price and the vesting period of the options granted. The outstanding options granted under the abovementioned plan vest over 2-4 years on service basis. Options not exercised will expire five years after the day of grant. The compensation costs charged against income for the 2011 Share Incentive Plan were comprised as follows:
|  | Years Ended December 31, |
|  | 2 0 2 2 |  |  | 2 0 2 1 |  |  | 2 0 2 0 |
|  | U.S. dollars in thousands |
Cost of revenues |  | $ | 63 |  |  | $ | 49 |  |  | $ | 65 |
Research and development expenses |  |  | 159 |  |  |  | 90 |  |  |  | 109 |
Selling and marketing expenses |  |  | 1 |  |  |  | 4 |  |  |  | 9 |
General and administrative expenses |  |  | 35 |  |  |  | 28 |  |  |  | 30 |
|  | $ | 258 |  |  | $ | 171 |  |  | $ | 213 |
Under Section 102 of the Israeli Income Tax Ordinance, pursuant to an election made by the Company thereunder, Israeli employees (except for employees who are deemed “Controlling Members” under the Israeli Income Tax Ordinance) are subject to a lower tax rate on part of the capital gains accruing to them in respect of Section 102 awards. However, the Company is not allowed to claim as an expense for tax purposes the amounts credited to such employees.
| 1) | The following is a summary of the status of the 2011 Share Incentive Plan as of December 31, 2022, 2021 and 2020, and changes during the years ended on those dates:
|  | Years Ended December 31, |
|  | 2 0 2 2 |  |  | 2 0 2 1 |  |  | 2 0 2 0 |
|  | Number |  |  | Weighted average exercise price |  |  | Number |  |  | Weighted average exercise price |  |  | Number |  |  | Weighted average exercise price |
Options outstanding at the beginning of year |  |  | 269,500 |  |  | $ | 0.003 |  |  |  | 266,500 |  |  | $ | 0.003 |  |  |  | 352,000 |  |  | $ | 0.23 |
Changes during year: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Granted (a) |  |  | 304,000 |  |  | $ | 0.003 |  |  |  | 172,000 |  |  | $ | 0.003 |  |  |  | 64,000 |  |  | $ | 0.003 |
Exercised |  |  | (67,000 | ) |  | $ | 0.003 |  |  |  | (71,500 | ) |  | $ | 0.003 |  |  |  | (89,500 | ) |  | $ | 0.003 |
Forfeited |  |  | (54,000 | ) |  | $ | 0.003 |  |  |  | (96,500 | ) |  | $ | 0.003 |  |  |  | (56,000 | ) |  | $ | 1.233 |
Expired |  |  | - |  |  | $ | 0.003 |  |  |  | (1,000 | ) |  | $ | 0.003 |  |  |  | (4,000 | ) |  | $ | 2.688 |
Options outstanding at the end of year |  |  | 452,500 |  |  | $ | 0.003 |  |  |  | 269,500 |  |  | $ | 0.003 |  |  |  | 266,500 |  |  | $ | 0.003 |
Options exercisable at the end of year |  |  | 25,500 |  |  | $ | 0.003 |  |  |  | 30,000 |  |  | $ | 0.003 |  |  |  | 23,000 |  |  | $ | 0.003 |
Weighted average grant date fair value of options granted during the year (b) |  |  |  |  |  | $ | 1.58 |  |  |  |  |  |  | $ | 1.79 |  |  |  |  |  |  | $ | 1.32 |
(a) | In the years ended December 31, 2022 and 2021 and 2020, the options were granted with an exercise price equal to par value of NIS 0.01 ($0.003).
(b) | The fair value of each stock option granted is computed on the date of grant according to the Black-Scholes option pricing model with the following assumptions:
|  | Years Ended December 31, |
|  | 2 0 2 2 |  |  | 2 0 2 1 |  |  | 2 0 2 0 |
Dividend yield |  |  | 9.69 | % |  |  | 8.73 | % |  |  | 10.3 | %
Expected volatility* |  |  | 30 | % |  |  | 34 | % |  |  | 22 | %
Average risk-free interest rate |  |  | 1.99 | % |  |  | 0.81 | % |  |  | 0.53 | %
Expected average term - in years |  |  | 3.88 |  |  |  | 3.88 |  |  |  | 3.88 |
* | Volatility is based on historical volatility of the Company’s share price for periods matching the expected term of the option until exercise.
As of December 31, 2022, there were approximately $623 thousand of total unrecognized compensation costs, net of expected forfeitures, related to unvested share-based compensation awards granted under the 2011 Share Incentive Plan. The costs are expected to be recognized over a weighted average period of 1.54 years.
| 2) | The following table summarizes information about options outstanding and exercisable as of December 31, 2022:
|  |  | Options Outstanding |  |  | Options Exercisable |
|  |  | Number |  |  | Weighted |  |  |  |  |  | Number |  |  | Weighted |  |  |  |
|  |  | outstanding |  |  | average |  |  | Weighted |  |  | exercisable |  |  | average |  |  | Weighted |
Range of |  |  | at |  |  | remaining |  |  | average |  |  | at |  |  | remaining |  |  | average |
exercise |  |  | December 31, |  |  | contractual |  |  | exercise |  |  | December 31, |  |  | contractual |  |  | exercise |
prices |  |  | 2022 |  |  | life |  |  | price |  |  | 2022 |  |  | life |  |  | price |
|  |  |  |  |  | Years |  |  |  |  |  |  |  |  | Years |  |  |  |
$ | 0.003 |  |  |  | 452,500 |  |  |  | 3.7 |  |  | $ | 0.003 |  |  |  | 25,500 |  |  |  | 1.45 |  |  | $ | 0.003 |
The total intrinsic value of options exercised during the years ended December 31, 2022, 2021 and 2020 were approximately $184 thousand, $235 thousand and $212 thousand, respectively. As of December 31, 2022 the aggregate intrinsic value of the outstanding options is $949 thousand, and the aggregate intrinsic value of the exercisable options is $53 thousand.

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI https://asc.fasb.org/topic&trid=2208762 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 14 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 14 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 18 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (g) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 18 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (h) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 14 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 18 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 16 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (i) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(e)(1)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 40 -Section 50 -Paragraph 6 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration